| Purity: | 99% |
|---|---|
| Type: | Auxiliaries and Other Medicinal Chemicals |
| CAS No.: | 7491-74-9 |
Quick Details
Specifications
Name: Piracetam
CAS ＃: 7491-74-9
White powder
Assay: 99%
Chemical name: 2-oxo-1-pyrrolidine acetamide
By name: Nootropil
Description
Piracetam is a nootropic drug in the recetams group,with chemical name 2-oxo-1-pyrrolidine acetamide.It shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid.
Piracetam is a cyclic derivative of the United States,it is not approved by the FDA for any medical use and it is not permitted to be sold as a dietary the UK,piracetam is prescribed mainly for myoclonus,but is used off-label for other conditions.Evidence to support its use for many conditions is unclear.
Piracetam is useful as a long-term treatment for clotting,coagulation,and vasospastic disorders as Raynaud's phenomenon and deep-vein thrombosis.It is an extremely safe anti-thrombotic agent that operate through the novel mechanism of inhibiting platelet aggregation and enhancing blood-cell deformability.
Some sources suggest that piracetam's overall effect on lowering depression and anxiety is higher than on improving memory.However,depression is reported to be an occasional adverse effect of piracetam.
Piracetam has positive therapeutic effects on adolescents with closed craniocerebral trauma (CCT). Treatment with piracetam was initiated 1.5 to 5 years after trauma.
CAS ＃: 7491-74-9
White powder
Assay: 99%
Chemical name: 2-oxo-1-pyrrolidine acetamide
By name: Nootropil
Description
Piracetam is a nootropic drug in the recetams group,with chemical name 2-oxo-1-pyrrolidine acetamide.It shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid.
Piracetam is a cyclic derivative of the United States,it is not approved by the FDA for any medical use and it is not permitted to be sold as a dietary the UK,piracetam is prescribed mainly for myoclonus,but is used off-label for other conditions.Evidence to support its use for many conditions is unclear.
Piracetam is useful as a long-term treatment for clotting,coagulation,and vasospastic disorders as Raynaud's phenomenon and deep-vein thrombosis.It is an extremely safe anti-thrombotic agent that operate through the novel mechanism of inhibiting platelet aggregation and enhancing blood-cell deformability.
Some sources suggest that piracetam's overall effect on lowering depression and anxiety is higher than on improving memory.However,depression is reported to be an occasional adverse effect of piracetam.
Piracetam has positive therapeutic effects on adolescents with closed craniocerebral trauma (CCT). Treatment with piracetam was initiated 1.5 to 5 years after trauma.